Kelly Metcalfe

Professor and Associate Dean, Research & External Relations

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kelly Metcalfe serves as the Associate Dean of Research & External Relations at the University of Toronto, Canada. Her research primarily focuses on hereditary breast and ovarian cancer, BRCA1 and BRCA2 gene mutations, and the health impacts on patients with these conditions. Recent publications include studies on ovarian cancer risks post-breast cancer, psychological distress from multi-gene panel testing, and innovations in at-home breast oncology care.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (11)

Raymond H. Kim

University Health Network

CANADA

View details

Charlene Chu

Assistant Professor

University of Toronto

CANADA

View details

Susan Domchek

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

Graham Mann

Professor

University of Sydney

AUSTRALIA

View details

Ewa Grzybowska

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Joanne Kotsopoulos

CANADA

View details

George Charames

Assistant Professor

University of Toronto

CANADA

View details

Andrea Eisen

McMaster University

CANADA

View details

Navpreet Kamboj

Teaching Assistant

University of Toronto

CANADA

View details

Nancy Baxter

Professor and Head of School

University of Melbourne

AUSTRALIA

View details

Paul Cohen

University of Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kelly Metcalfe

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant

At-home Breast Oncology care Delivered with EHealth solutions (ABODE) study protocol: a randomised controlled trial

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Health-Related Quality of Life of Adults and Adolescents with Sickle Cell Disease after Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Designing the User Interface of a Nitroglycerin Dose Titration Decision Support System: User-Centered Design Study

Recontact to return new or updated PALB2 genetic results in the clinical laboratory setting

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations

Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers

Abstract GS02-04: Surgical Treatment of Women with Breast Cancer and a BRCA1 Mutation: An International Analysis of the Impact of Bilateral Mastectomy on Survival

Abstract PS10-01: Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2

Psychological distress following multi-gene panel testing for hereditary breast and ovarian cancer risk

The ABODE Study – At home Breast Oncology care Delivered with E-health solutions

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial

Patient Outcomes after Fat Grafting to the Radiated Chest Wall before Delayed Two-stage Alloplastic Breast Reconstruction

Abstract 4212: Comparison of thirty-year population-based incidence rates of invasive lobular vs ductal vs mixed breast carcinoma in Ontario, Canada

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Abstract P4-03-11: Population-based survival outcomes of pure vs mixed invasive lobular breast carcinoma in Ontario, Canada

Abstract P5-03-07: Prevalence of Pathogenic Variants in Cancer Predisposition Genes in Women with Young Onset Breast Cancer

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?

Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.

Collaborators (11)

Raymond H. Kim

Charlene Chu

Susan Domchek

Graham Mann

Ewa Grzybowska

Joanne Kotsopoulos

George Charames

Andrea Eisen

Navpreet Kamboj

Nancy Baxter

Paul Cohen

Make your next move.